Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-β1-induced epithelial-to-mesenchymal transition

Journal of Ethnopharmacology

Volumn 127, Issue 3, 2010, Pages 631-640

  Wang, Qing Lan ^a,b   Yuan, Ji Li ^a   Tao, Yan Yan ^a,b   Zhang, Yue ^b   Liu, Ping ^b,c   Liu, Cheng Hai ^a,b,c  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Epithelial to mesenchymal transition; Fuzheng Huayu recipe; Renal interstitial fibrosis; Transforming growth factor beta1; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIFIBROTIC AGENT; CHINESE DRUG; CYTOKERATIN 18; FUZHENG HUAYU RECIPE; GYNOSTEMMA PENTAPHYLLAMMAK EXTRACT; NATURAL PRODUCT; PERSICA EXTRACT; PLANT EXTRACT; POLLEN EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EPITHELIUM CELL; FRUCTUS SCHISANDRAE CHINENSIS; GYNOSTEMMA PENTAPHYLLAMAMAK; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; MEDICINAL PLANT; MESENCHYME CELL; MYCELIUM; NONHUMAN; PERSICA; PINE; POLLEN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SALVIA MILTIORRHIZA; SEMEN PERSICAE; SIGNAL TRANSDUCTION; SNAKE; SPERM; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BENZAMIDES; BIOLOGICAL TRANSPORT; CADHERINS; COLLAGEN; DIOXOLES; DRUGS, CHINESE HERBAL; EPITHELIAL CELLS; FIBROSIS; FUNGI; HUMANS; HYDROXYPROLINE; KERATIN-18; KIDNEY; KIDNEY DISEASES; MALE; MESODERM; PHYTOTHERAPY; PLANTS, MEDICINAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN E;

RATTUS;

EID: 76149139723     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.12.011     Document Type: Article

References (29)

1. Bottinger E.P., Bitzer M. TGF-beta signaling in renal disease. Journal of the American Society of Nephrology 2002, 13:2600-2610.
2. Di Sario A., Candelaresi C., Omenetti A., Benedetti A. Vitamin E in chronic liver diseases and liver fibrosis. Vitamins and Hormones: Advances in Research and Applications 2007, 76:551-573.
3. Fan J.M., Ng Y.Y., Hill P.A., Nikolic-Paterson D.J., Mu W., Atkins R.C., Lan H.Y. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney International 1999, 56:1455-1467.
4. Frantz S. Drug discovery: playing dirty. Nature 2005, 437:942-943.
5. Hemmati A.A., Nazari Z., Ranjbari N., Torfi A. Comparison of the preventive effect of vitamin C and E on hexavalent chromium induced pulmonary fibrosis in rat. Inflammopharmacology 2008, 16:195-197.
6. Huang S.H., Schall J.I., Zemel B.S., Stallings V.A. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. Journal of Pediatrics 2006, 148:556-559.
7. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Molecular Pharmacology 2002, 62:65-74.
8. Iwama H., Amagaya S., Ogihara Y. Effect of shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method. Journal of Ethnopharmacology 1987, 21:45-53.
9. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. Journal of Clinical Investigation 2002, 110:341-350.
10. Jamall I.S., Finelli V.N., Que Hee S.S. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Analytical Biochemistry 1981, 112:70-75.
11. Jiang Z.H., Cui H.Y., Liu C.H., Liu C., Liu P., Xu L.M., Hu Y.Y., Yuan J.L., Li F.H. Effects of Fuzheng Huayu recipe on renal toxic interstitial fibrosis in rats. Journal of Chinese Integrative Medicine 2004, 2:358-360.
12. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation 2003, 112:1776-1784.
13. Li J.H., Zhu H.J., Huang X.R., Lai K.N., Johnson R.J., Lan H.Y. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. Journal of the American Society of Nephrology 2002, 13:1464-1472.
14. Li M.X., Liu B.C. Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis. Chinese Medical Journal 2007, 120:1925-1930.
15. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. Journal of the American Society of Nephrology 2004, 15:1-12.
16. Massague J. How cells read TGF-beta signals. Nature Reviews Molecular Cell Biology 2000, 1:169-178.
17. Phanish M.K., Wahab N.A., Colville-Nash P., Hendry B.M., Dockrell M.E. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochemical Journal 2006, 393:601-607.
18. Schnaper H.W., Hayashida T., Hubchak S.C., Poncelet A.C. TGF-beta signal transduction and mesangial cell fibrogenesis. American Journal of Physiology - Renal Physiology 2003, 284:F243-252.
19. Shen H.F., Li Y.Q., Jin R.M., Li H., Min L. An experimental serum pharmacological study on an application method in traditional Chinese medicine for treatment and prevention of asthma. Journal of Chinese Integrative Medicine 2007, 5:70-73.
20. Wang Q.L., Yuan J.L., Tao Y.Y., Hu Y.Y., Liu C.H. Effect of salvianolic acid B on renal interstitial fibrosis rats induced by HgCl2. Pharmacology and Clinics of Chinese Materia Medica 2008, 24:12-15.
21. Wang Y., Cui K., Zhao H., Li D., Wang W., Zhu Y. Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway. Journal of Ethnopharmacology 2009, 122:221-226.
22. Wheelock M.J., Johnson K.R. Cadherins as modulators of cellular phenotype. Annual Review of Cell and Developmental Biology 2003, 19:207-235.
23. Yang J., Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. American Journal of Pathology 2001, 159:1465-1475.
24. Yang J., Liu Y. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. American Journal of Physiology - Renal Physiology 2003, 284:F349-F357.
25. Yu L., Border W.A., Anderson I., McCourt M., Huang Y., Noble N.A. Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney International 2004, 66:1774-1784.
26. Yu L., Noble N.A., Border W.A. Therapeutic strategies to halt renal fibrosis. Current Opinion in Pharmacology 2002, 2:177-181.
27. Yuan J.l., Liu C.H., Jiang Z.H., Zhang Y., Liu C. Effects of oral administration of HgCl2 on renal interstitial fibrosis in rats. ACTA Laboratorium Animalis Scientia Sinica 2006, 14:93-95.
28. Yuan J.L., Liu C.H., Zhang Y., Jiang Z.H., Liu C. The mechanism of lipid peroxidation in renal interstitial fibrosis in rats intoxicated by mercuric chloride. Chinese Journal of Integrated Traditional and Western Nephrology 2008, 9:403-407.
29. Zhao C.Q., Wu Y.Q., Xu L.M. Curative effects of Fuzheng Huayu capsules on hepatic fibrosis and the functional mechanisms: a review. Journal of Chinese Integrative Medicine 2006, 4:467-472.